Vered Bisker-Leib's Net Worth
$1.45 Million
Who is Vered Bisker-Leib?
Vered Bisker-Leib has an estimated net worth of $1.45 Million. This is based on reported shares across multiple companies, which include Compass Therapeutics, Inc., Ayala Pharmaceuticals, Inc., and Ayala Pharmaceuticals, Inc..
SEC CIK
Vered Bisker-Leib's CIK is 0001814093
Past Insider Trading and Trends
2023 was Vered Bisker-Leib's most active year for acquiring shares with 5 total transactions. Vered Bisker-Leib's most active month to acquire stocks was the month of December. 2022 was Vered Bisker-Leib's most active year for disposing of shares, totalling 5 transactions. Vered Bisker-Leib's most active month to dispose stocks was the month of October. 2024 saw Vered Bisker-Leib paying a total of $3,383,531.25 for 3,506,250 shares, this is the most they've acquired in one year. In 2023 Vered Bisker-Leib cashed out on 85,665 shares for a total of $96,622.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43
CHIEF EXECUTIVE OFFICERVered Bisker-Leib owns 3,124,426 units of Common Stock which is worth $4,467,929.18. From 2020 to 2024 Vered Bisker-Leib acquired a total of 2,753,125 shares in Compass Therapeutics, Inc. at a cost of $3,383,531.25, Vered also disposed a total of 160,374 shares of Compass Therapeutics, Inc. equalling to $368,653.83.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.55% | -49.20K |
$1.45 | -$71,337.10 | 3.12M |
Feb 8
| |||
Form 4
| +123.42% | 1.75M |
$1.93 | $3,383,531.25 | 3.17M |
Jan 9
| |||
Form 4
| -4.34% | -64.42K |
$1.50 | -$96,622.50 | 1.42M |
Nov 17
| |||
Form 4
| +36.87% | 400K |
—
|
—
| 1.48M |
Feb 8
| |||
Form 4
| -2.26% | -24.50K |
$4.23 | -$103,707.93 | 1.06M |
Nov 22 - Nov 25
| |||
Form 4
| -1.01% | -22.26K |
$4.37 | -$96,986.30 | 2.19M |
Nov 18 - Nov 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +116.87% | 600K |
—
|
—
| 1.11M |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ayala Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ayala Pharmaceuticals, Inc. (ADXS) Snapshot price: $0.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||